Corteva Inc Stock Price, News & Analysis

Corteva (CTVA) announced two insect-management products: Goltrevo bioinsecticide, a microbial solution based on Beauveria bassiana 203, and Varpelgo active, a nature‑inspired synthetic for chewing pests.

Goltrevo targets sap‑feeding and chewing pests (whiteflies, aphids, corn leafhopper) with longer shelf life and lower resistance risk; commercial sales forecast as early as 2027 in Latin America pending approvals. Varpelgo targets chewing pests and offers a seed‑applied wireworm solution; first sales expected in early 2030s in Asia Pacific and Latin America, pending trials and regulatory review.

Corteva (NYSE: CTVA) reported strong 3Q and YTD 2025 results and raised full-year guidance on Nov 4, 2025. YTD net sales were $13.49B (up 4%) and Operating EBITDA was $3.40B. GAAP YTD income from continuing ops was $1.74B and GAAP EPS was $2.54. The company now expects 2025 net sales of $17.7B–$17.9B, Operating EBITDA $3.8B–$3.9B, and Operating EPS $3.25–$3.35; a preliminary 2026 Operating EBITDA midpoint view is $4.1B. Seed and Crop Protection showed double‑digit volume gains in new products/biologicals and margin expansion in both segments. The company reiterated separation plans for two public companies in H2 2026 and expects ~$1.0B of share repurchases in 2025.

Corteva (NYSE: CTVA) announced a common stock dividend of $0.18 per share, payable December 15, 2025 to shareholders of record on December 1, 2025. The Board authorized the dividend at its October 31, 2025 meeting.

The release also notes preferred stock dividends declared by EIDP, a wholly owned Corteva subsidiary: $1.125 per share on the $4.50 series and $0.875 per share on the $3.50 series, both payable January 23, 2026 to holders of record on January 8, 2026.

Corteva (NYSE: CTVA) announced a common stock dividend of $0.18 per share, payable December 15, 2025 to shareholders of record on December 1, 2025. The Board authorized the dividend at its October 31, 2025 meeting.

The release also notes preferred stock dividends declared by EIDP, a wholly owned Corteva subsidiary: $1.125 per share on the $4.50 series and $0.875 per share on the $3.50 series, both payable January 23, 2026 to holders of record on January 8, 2026.

Corteva (NYSE: CTVA) has scheduled its third quarter 2025 earnings release for Tuesday, November 4, 2025, after market close. The company will host a live webcast presentation on Wednesday, November 5, 2025, at 9:00 a.m. ET.

The earnings presentation will be accompanied by slides available on Corteva's Investor Events and Presentations webpage. A replay of the webcast will remain accessible on the same page until November 5, 2026.

Corteva (NYSE: CTVA) announced plans to separate into two independent, publicly traded companies through a tax-free spin-off expected to complete in H2 2026. The separation will create:

1. New Corteva: Will comprise the Crop Protection business, with estimated 2025 net sales of $7.8 billion (44% of current sales). The company will focus on operational excellence and innovative solutions, including biologicals.

2. SpinCo: Will contain the Seed business, including the Pioneer® brand, with projected 2025 net sales of $9.9 billion (56% of current sales). Current Corteva CEO Chuck Magro will lead SpinCo, while Greg Page will chair New Corteva.

Both companies will maintain investment-grade credit ratings and pursue distinct growth strategies. The separation aims to enhance strategic focus, optimize capital allocation, and accelerate value creation for shareholders.

Corteva (NYSE: CTVA) has appointed Jennifer Johnson as its new Chief Legal Officer, effective September 15, 2025. Johnson, who previously served as general counsel at International Flavors and Fragrances (IFF), will oversee Corteva's global legal function and join the executive leadership team.

The current chief legal officer, Cornel Fuerer, will retain oversight of public affairs and continue as corporate secretary until the end of 2025, after which he will serve as strategic advisor until his retirement in 2026. Johnson brings significant experience in agriculture technology, having started her in-house legal career at DuPont supporting the Pioneer business, and holds a Ph.D. in plant biology along with extensive experience in biotechnology and patent law.

Corteva (NYSE:CTVA) reported strong financial results for Q2 and 1H 2025, leading to increased full-year guidance. The company achieved Q2 net sales of $6.46B (up 6% YoY) and operating EBITDA of $2.16B (up 13% YoY).

Key performance drivers included strong North American corn and soybean market position, with Seed net sales up 2% to $7.24B in 1H 2025, and Crop Protection sales increasing 3% to $3.63B. The company demonstrated significant margin expansion, with Operating EBITDA margin improving by 215 basis points in Q2.

Corteva raised its 2025 guidance, projecting net sales of $17.6-17.8B and operating EBITDA of $3.75-3.85B. The company plans to return value to shareholders through a $1B share repurchase program in 2025.

Corteva (NYSE: CTVA) has announced its fifth consecutive dividend increase since its 2019 spin-off, raising the quarterly dividend by 6% to $0.18 per share. The dividend will be payable on September 15, 2025, to shareholders of record as of September 2, 2025.

The increase reflects the company's successful execution of its strategy focused on margin expansion and sustainable growth through innovation and customer engagement. Additionally, EIDP, Inc., a wholly owned subsidiary of Corteva, declared preferred stock dividends of $1.12-1/2 per share for the $4.50 series and $0.87-1/2 per share for the $3.50 series, both payable October 24, 2025.